Table of Content

1. Introduction
   1.1. Market Definition & Scope
   1.2. Market Ecosystem
   1.3. Currency & Limitations
   1.4. Key Stakeholders

2. Research Methodology
   2.1. Research Process
   2.2. Data Collection & Validation
      2.2.1. Secondary Research
      2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
   2.3. Market Sizing and Forecast
      2.3.1. Market Size Estimation Approach
      2.3.2. Growth Forecast Approach
      2.3.3. Market Share Analysis
   2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights
   4.1. Overview
   4.2. Factors Affecting Market Growth
      4.2.1. Drivers
         4.2.1.1. Rising Prevalence of Chronic Diseases & the Increasing Geriatric Population
         4.2.1.2. High Burden of Infectious Diseases
         4.2.1.3. Growing Focus on the Development of POC IVD Assays
         4.2.1.4. Rising Healthcare Expenditures
      4.2.2. Restraints
         4.2.2.1. Evolving Regulatory Landscape
      4.2.3. Opportunities
         4.2.3.1. Emerging Economies
         4.2.3.2. Use of Advanced Technologies in IVD Assay Development
      4.2.4. Challenges
         4.2.4.1. Maintaining Product Quality & Protecting Proprietary Information
      4.2.5. Macro Indicators
   4.3. Adjacent Market Analysis
   4.4. IVD Assay Development Market: Regulatory Landscape
      4.4.1. North America
         4.4.1.1. U.S.
         4.4.1.2. Canada
      4.4.2. Europe
      4.4.3. Asia-Pacific
         4.4.3.1. Japan
         4.4.3.2. China
         4.4.3.3. India
      4.4.4. Latin America
      4.4.5. Middle East & Africa
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of Substitutes
      4.5.4. Threat of New Entrants
      4.5.5. Degree of Competition

5. IVD Assay Development Market Assessment?by Offering
   5.1. Overview
   5.2. IVD Assay Development Services
   5.3. IVD Assay Stability Testing
   5.4. IVD Packaging Development Services
   5.5. Regulatory Support
   5.6. Other offerings

6. IVD Assay Development Market?by Technology
   6.1. Overview
   6.2. Immunoassay/Immunochemistry
   6.3. Molecular Diagnostics
   6.4. Clinical Chemistry/Biochemistry
   6.5. Hematology
   6.6. Microbiology
   6.7. Urinalysis

7. IVD Assay Development Market Assessment?by Application
   7.1. Overview
   7.2. Infectious Diseases
   7.3. Oncology
   7.4. Diabetes
   7.5. Cardiology
   7.6. Other Applications

8. IVD Assay Development Market Assessment?by Geography
   8.1. Overview
   8.2. North America
      8.2.1. U.S.
      8.2.2. Canada
   8.3. Europe
      8.3.1. Germany
      8.3.2. U.K.
      8.3.3. France
      8.3.4. Italy
      8.3.5. Spain
      8.3.6. Rest of Europe
   8.4. Asia-Pacific
      8.4.1. China
      8.4.2. Japan
      8.4.3. India
      8.4.4. Australia
      8.4.5. South Korea
      8.4.6. Rest of Asia-Pacific
   8.5. Latin America
      8.5.1. Brazil
      8.5.2. Mexico
      8.5.3. Rest of Latin America
   8.6. Middle East & Africa

9. Competition Analysis
   9.1. Overview
   9.2. Competitive Benchmarking
   9.3. Competitive Dashboard
      9.3.1. Industry Leaders
      9.3.2. Market Differentiators
      9.3.3. Vanguards
      9.3.4. Emerging Companies
   9.4. Market Ranking, by Key Players (2023)

10. Company Profiles (Business Overview, Financial Overview, Product Portfolio, Strategic Developments, And SWOT Analysis*)
   10.1. Creative Biolabs, Inc.
   10.2. Avioq, Inc.
   10.4. Thermo Fisher Scientific Inc.
   10.5. Neodx Biotech Labs Pvt. Ltd.
   10.6. Merck KGaA
   10.7. PeploBio Ltd
   10.8. Icon Plc
   10.9. Savyon Diagnostics
   10.10. Maxim Biomedical, Inc.
   10.11. Eclevar Medtech
   10.12. Promega Corporation
   10.13. Future Diagnostics Solutions B.V.
            (Note: SWOT Analysis of the Top 5 Companies Will Be Provided)

11. Appendix
   11.1. Available Customization
   11.2. Related Reports



List of Figures

Figure 1?? ?Research Process?
Figure 2?? ?Secondary Sources Referenced for This Study?
Figure 3?? ?Primary Research Techniques?
Figure 4?? ?Key Executives Interviewed?
Figure 5?? ?Breakdown of Primary Interviews (Supply-Side & Demand-Side)?
Figure 6?? ?Market Sizing and Growth Forecast Approach?
Figure 7?? ?Global IVD Assay Development Market, by offering, 2024 Vs.2031 (USD Million)?
Figure 8?? ?Global IVD Assay Development Market, by Technology, 2024 Vs. 2031 (USD Million)?
Figure 9?? ?Global IVD Assay Development Market, by Application, 2024 Vs. 2031 (USD MILLION)?
Figure 10?? ?Global IVD Assay Development Market, by Geography, 2024 VS 2031 (USD Million)?
Figure 11?? ?Impact Analysis of Market Dynamics?
Figure 12?? ?GLOBAL Biopharmaceutical R&D Expenditure, 2016–2026 (USD Billion)?
Figure 13?? ?Estimated Number of New Cancer Cases, by Region, 2022 VS. 2030?
Figure 14?? ?Number of People with Diabetes Aged 20–79 Years, by Region, 2021 VS. 2030 VS. 2045 (in Million)?
Figure 15?? ?IVD Market Share, BY Technology, 2024?
Figure 16?? ?IVD Reagents Market, by Type, 2024 Vs. 2031 (USD Million)?
Figure 17?? ?IVD Contract Manufacturing Services Market, by Type, 2024 Vs. 2031 (USD Million)?
Figure 18?? ?Porter’s Five Forces Analysis?
Figure 19?? ?Global IVD Assay Development Market, by offering, 2024 VS. 2031 (USD Million)?
Figure 20?? ?IVD Assay Development Phases?
Figure 21?? ?Global IVD Assay Development Market, by Technology, 2024 VS. 2031 (USD Million)?
Figure 22?? ?Global IVD Assay Development Market, by Application, 2024 VS. 2031 (USD Million)?
Figure 23?? ?Estimated Number of New Cancer Cases, by Region, 2022–2030?
Figure 24?? ?Global IVD Assay Development Market, by Country/Region, 2024 Vs. 2031 (USD Million)?
Figure 25?? ?North America: IVD Assay Development Market Snapshot?
Figure 26?? ?Europe: IVD Assay Development Market Snapshot?
Figure 27?? ?France: Percentage of the Population Aged 65 Years and Above (2016–2020)?
Figure 28?? ?Number of HIV Tests Performed in Catalonia (Spain), 2014–2021?
Figure 29?? ?Asia-Pacific: IVD Assay Development Market Snapshot?
Figure 30?? ?China: Independent Medical Laboratories Market Size (USD Million)?
Figure 31?? ?Japan: Percentage of Aging Population (65 Years and Above), 2016-2050?
Figure 32?? ?Latin America: IVD Assay Development Market Snapshot?
Figure 33?? ?IVD Assay Development Market: Competitive Benchmarking (Based on Offering)?
Figure 34?? ?IVD Assay Development Market: Competitive Benchmarking (Based on Geography)?
Figure 35?? ?Competitive Dashboard: IVD Assay Development Market?
Figure 36?? ?Bio-Techne Corporation: Financial Snapshot (2023)?
Figure 37?? ?Thermo Fisher Scientific Inc.: Financial Snapshot (2023)?
Figure 38?? ?Merck KGaA: Financial Snapshot (2023)?
Figure 39?? ?ICON Plc: Financial Snapshot (2023)